Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential

Journal of Physical Science

Volumn 25, Issue 1, 2014, Pages 59-75

  Shah, Rohan ^a   Eldridge, Daniel ^a   Palombo, Enzo ^a   Harding, Ian ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Drug encapsulation; Hydrophilic lipophilic balance; Lipophilic and hydrophilic drugs; Solid lipid nanoparticles; Zeta potential

Indexed keywords

EMULSIFICATION; ENCAPSULATION; HYDROPHILICITY; MICROEMULSIONS; NANOPARTICLES; STABILITY; STEARIC ACID; SYSTEM STABILITY; ZETA POTENTIAL;

DRUG ENCAPSULATION; HYDROPHILIC DRUGS; HYDROPHILIC LIPOPHILIC BALANCE; PARTICLE SIZE MEASUREMENT; PHYSICOCHEMICAL PROPERTY; POLYDISPERSITY INDICES; SOLID LIPID NANOPARTICLE (SLN); SOLID LIPID NANOPARTICLES;

PARTICLE SIZE;

EID: 84921920664     PISSN: 16753402     EISSN: 21804230     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Kawabata, Y. et al. (2011). Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: Basic approaches and practical applications. Int. J. Pharm., 420, 1-10.
2. Das, S. et al. (2011). Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: Effects of process variables. Colloid Surf. B, 88, 483-489.
3. Harde, H., Das, M. & Jain, S. (2011). Solid lipid nanoparticles: An oral bioavailability enhancer vehicle. Expert Opin. Drug Del., 8, 1407-1424.
4. Noack, A., Hause, G. & Mäder, K. (2012). Physicochemical characterization of curcuminoid-loaded solid lipid nanoparticles. Int. J. Pharm., 423, 440-451.
5. Severino, P. et al. (2012). Current state-of-art and new trends on lipid nanoparticles (SLN and NLC) for oral drug delivery. J. Drug Delivery, DOI:10.1155/2012/750891.
6. Muller, R. H. & Keck, C. M. (2004). Challenges and solutions for the delivery of biotech drugs - a review of drug nanocrystal technology and lipid nanoparticles. J. Biotechnol., 113(1-3), 151-170.
7. Jain, S. et al. (2010). Design and development of solid lipid nanoparticles for topical delivery of an anti-fungal agent. Drug Delivery, 17, 443-451.
8. Tiwari, R. & Pathak, K. (2011). Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: Comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int. J. Pharm., 415, 232-243.
9. Blasi, P. et al. (2011). Lipid nanoparticles for brain targeting I. Formulation optimization. Int. J. Pharm., 419, 287-295.
10. Zara, G. P. et al. (2002). Intravenous administration to rabbits of non-stealth and stealth doxorubicin-loaded solid lipid nanoparticles at increasing concentrations of stealth agent: Pharmacokinetics and distribution of doxorubicin in brain and other tissues. J. Drug Target., 10(4), 327-335.
11. Puglia, C. et al. (2008). Lipid nanoparticles for prolonged topical delivery: An in vitro and in vivo investigation. Int. J. Pharm., 357, 295-304.
12. Cavalli, R. et al. (2002). Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int. J. Pharm., 238, 241-245.
13. Vitorino, C. et al. (2011). The size of solid lipid nanoparticles: An interpretation from experimental design. Colloid Surf. B, 84, 117-130.
14. Taguchi, G. & Konishi, S. (1987). Orthogonal arrays and linear graphs. Dearborn, MI: American Supplier Institute.
15. Varshosaz, J., Eskandari, S. & Tabbakhian, M. (2012). Freeze-drying of nanostructure lipid carriers by different carbohydrate polymers used as cryoprotectants. Carbohyd. Polym., 88(4), 1157-1163.
16. Kaur, I. P. et al. (2008). Potential of solid lipid nanoparticles in brain targeting. J. Contr. Release, 127, 97-109.
17. Das, S., Ng, W. K. & Tan, R. B. H. (2012). Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur. J. Pharm. Sci., 47, 139-151.
18. Martins, S. et al. (2012). Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles. Eur. J. Pharm. Sci., 45, 613-623.
19. Ghadiri, M. et al. (2012). Loading hydrophilic drug in solid lipid media as nanoparticles: Statistical modelling of entrapment efficiency and particle size. Int. J. Pharm., 424, 128-137.
20. Chen, C.-C. et al. (2010). Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: Physicochemical characterization and pharmacokinetics. Eur. J. Pharm. Biopharm., 74, 474-482.
21. Araujo, J. et al. (2010). Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int. J. Pharm., 393, 168-176.
22. Helgason, T. et al. (2009). Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). J. Colloid Interf. Sci., 334, 75-81.
23. Kovacevic, A. et al. (2011). Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure. Int. J. Pharm., 406, 163-172.
24. Freitas, C. & Müller, R. H. (1998). Effect of light and temperature on zeta potential and physical stability in solid lipid nanoparticle (SLN™) dispersions. Int. J. Pharm., 168, 221-229.